title: Antipsychotic-induced dyslipidemia treated with omega 3 fatty acid supplement in an 11-year-old psychotic child: a 1-year follow-up.
authors.forename: Simone
authors.initials: S
authors.lastname: Pisano
authors.forename: Antonella
authors.initials: A
authors.lastname: Gritti
authors.forename: Gennaro
authors.initials: G
authors.lastname: Catone
authors.forename: Antonio
authors.initials: A
authors.lastname: Pascotto
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D019587:Dietary Supplements; D050171:Dyslipidemias / Q000139:chemically induced / Q000188:drug therapy*; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011618:Psychotic Disorders / Q000188:drug therapy*; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome; D015430:Weight Gain / Q000187:drug effects
chemical_list: D014150:Antipsychotic Agents; D015525:Fatty Acids, Omega-3; D018967:Risperidone